spacer
home > pmps > winter 2018 > every drop counts
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Every Drop Counts

Drugs based on blood plasma or other biological microorganisms are – in comparison to chemical-based materials – expensive in their extraction. It is equally costly and complex to process these products to obtain a safe API. Even the smallest quantities represent high financial value. All processes, in particular filling and closing, and the upstream and downstream functions must be designed to generate the maximum output of pharmaceuticals from an existing product quantity.

The biopharmaceutical market is continually growing. These drugs might have the greatest potential to solve the medical challenges of the near future, such as multi-resistant germs and rare diseases.

To meet the special requirements of these expensive pharmaceuticals, the entire filling and packaging process has been analysed and revised. During this, waste caused by underfilling should be avoided, as should overfilling. If the overfill fluctuates within a defined tolerance, expensive product is involuntarily ‘given away’. On the other hand, if the fill volume is outside the tolerance, the container must be rejected. Many other factors in the manufacturing process have a significant impact on the maximised product yield, according to the experts at the Schwäbisch Hall company. These factors are explained in more detail later.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Matthias Poslovski, a graduate mechanical engineer, has been with the Optima Group since 1998. He began his career with the company as Sales Manager of the former division Inova pharma systems. From 2000 to 2002, Matthias managed the Optima division of Kugler; its expertise was in non-sterile filling and packaging technology. Today, he holds the title of Director Technical Sales at Optima Pharma. His responsibilities encompass the overall support of sales worldwide. 
spacer
Matthias Poslovski
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

BioIVT Publishes New Research On the Mechanisms Underlying the C-DILI Assay

BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology.1
More info >>

White Papers
 
Industry Events

PDA Parenteral Packaging 2019

19-20 March 2019, Hilton Molino Stucky, Venice, Italy

PDA Europe’s Conference has become a must-attend event for all professionals in the Parenteral Packaging arena. Join us in Venice in March 2019 to continue and further deepen scientific advancements and our ongoing professional discourse of latest on primary packaging technologies and business trends. This conference and the accompanying exhibition address quality of components and cont­ainers, container closure development and integrity testing as well as aspects of processing, product distribution and storage.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement